Successful ABO incompatible heart transplantation after desensitization therapy in an older child
Pediatric Transplantation · 2023
DOI: 10.1111/petr.14459 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2023. Verfasst von Annemarie Krauss und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology at the University of Alberta, Deutsches Herzzentrum, Berlin, Germany. Hauptthemen laut MEDLINE: Hemagglutinins, Heart Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
ABO‐incompatible heart transplantation (HTx) has become a standard procedure for children below 2 years of age due to an immunologically immature immune system and associated low isohemagglutinin titers.
Methods
We report a case of an ABO‐incompatible HTx (recipient blood group O, donor blood group A) at the age of 5 years and 11 months with a fully matured immune system and previously high isohemagglutinin titers that diminished as a result of human leucocyte antigen (HLA) desensitization therapy with rituximab and immunoglobulins.
Results
The anti‐A titer at the time of HTx was 1:16 with post‐transplant isoagglutinin titers never exceeding 1:4 without any signs of rejection with now 3 years of post‐HTx follow‐up.
Conclusions
ABO isohemagglutinin titers should be routinely assessed in children undergoing desensitization therapy since ABOi transplantation can be considered in selected cases to expand the donor pool with the option of crossing the ABO barrier to find a better‐matched allograft.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Cardiology at the University of Alberta, Deutsches Herzzentrum, Berlin, Germany.
- Departments of Pediatrics, Surgery, Medical Microbiology/Immunology and Laboratory Medicine/Pathology, University of Alberta, Alberta Transplant Institute, Edmonton, Alberta, Canada.
- Canadian Donation and Transplantation Research Program, Edmonton, Alberta, Canada.
- Division of Pediatric Cardiology at the University of Alberta, Edmonton, Alberta, Canada.
- Department of Laboratory Medicine and Pathology, University of Alberta and Alberta Precision Laboratories, Edmonton, Alberta, Canada.
- Division of Pediatric Cardiac Surgery, Stollery Children's Hospital, Edmonton, Alberta, Canada.
ORCID-Profile: Annemarie Krauss, Lori J West, Jennifer Conway, Michael Khoury, Susann Nahirniak, Anne Halpin, Simon Urschel
Zitieren
APA
Krauss, A., West, L. J., Conway, J., Khoury, M., Nahirniak, S., Halpin, A., Al Aklabi, M., & Urschel, S. (2023). Successful ABO incompatible heart transplantation after desensitization therapy in an older child. Pediatric Transplantation. https://doi.org/10.1111/petr.14459
Vancouver
Krauss A, West LJ, Conway J, Khoury M, Nahirniak S, Halpin A, et al. Successful ABO incompatible heart transplantation after desensitization therapy in an older child. Pediatric Transplantation. 2023. doi:10.1111/petr.14459
BibTeX
@article{Krauss2023,
author = {Krauss, Annemarie and West, Lori J and Conway, Jennifer and Khoury, Michael and Nahirniak, Susann and Halpin, Anne and Al Aklabi, Mohammed and Urschel, Simon},
title = {Successful ABO incompatible heart transplantation after desensitization therapy in an older child},
journal = {Pediatric Transplantation},
year = {2023},
doi = {10.1111/petr.14459}
}
EUVIMED